Stalevo and Breastfeeding
It is not known whether Stalevo (carbidopa-levodopa-entacapone) and breastfeeding is a safe combination. Studies show that the various components of the medication pass through breast milk, but it is unclear if this will cause problems in the nursing infant. Theoretically, it may affect a woman's ability to breastfeed successfully. Before taking Stalevo, breastfeeding women should ask their healthcare provider about the potential risks.
It is not known whether Stalevo® (carbidopa-levodopa-entacapone) is safe for use during breastfeeding. Therefore, you should talk with your healthcare provider before taking the drug if you are breastfeeding or plan to start.
Studies have shown that carbidopa and entacapone pass through breast milk in rats, although it is not known whether they also do so in humans. Studies have shown that levodopa passes through breast milk in humans. However, it is not known whether this causes any problems for the nursing infant. More importantly, Stalevo can decrease the level of prolactin, a hormone that is important for breastfeeding. Theoretically, the drug may negatively affect a woman's ability to breastfeed successfully.
You should talk with your healthcare provider about Stalevo and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Stalevo and breastfeeding that is right for you.